Início › Lúpus › Texas

Ensaios clínicos de Lúpus em Texas

26 estudos para Lúpus estão buscando participantes em locais em Texas.

Cidades em Texas

Texto oficial do estudo (Inglês)

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Research Site, El Paso
Research Site, Houston

RecrutandoFase 3

Idades de 5 a 17 · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT05835310

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

Amarillo Medical Specialists Rheumatology, Amarillo
Amarillo Center for Clinical Research, Amarillo
Arthritis and Rheumatology Research Institute, Frisco
e mais 5

RecrutandoFase 3

Idades de 18 a 75 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07438496

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

Epic Medical Research /ID# 279180, Red Oak

RecrutandoFase 1

Idades de 18 a 75 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07607964

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

Research Site, Austin
Research Site, Baytown
Research Site, Colleyville
e mais 3

RecrutandoFase 3

Idades de 18 a 70 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07430306

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

UT Southwestern Simmons Cancer Center - RedBird, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
e mais 2

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT03816345

Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

Research Site, Allen
Research Site, Mesquite

RecrutandoFase 1

Idades de 18 a 65 · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT07201558

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

Amarillo Center for Clinical Research, Amarillo
Precision Comprehensive Clinical Research Solutions - Colleyville, Colleyville
Precision Comprehensive Clinical Research Solutions, Euless
e mais 4

RecrutandoFase 2

Idades de 18 a 74 · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07409181

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

Baylor College of Medicine, Houston

RecrutandoFase 1

Idades de 18 a 60 · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT06975787

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

North Texas Center for Clinical Research, Frisco
Accurate Clinical Research, Humble

RecrutandoFase 3

Idades de 18 a 75 · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT07355218

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

The University of Texas Southwestern Medical Center, Dallas

RecrutandoFase 2

Idades de 12 a 70 · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT07570862

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

Allen Arthritis, Allen
Arthritis and Rheumatology Research Institute PLLC, Allen
Arthritis Care of Texas, Corpus Christi

RecrutandoFase 3

Idades de 18 a 75 · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT07332481

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Sl0044 50738, Bellaire
Sl0044 50781, El Paso
Sl0044 50673, Fort Worth
e mais 7

RecrutandoFase 3

Idades 16 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT06617325

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

Arthritis Care of Texas - Corpus Christi, Corpus Christi
Lone Star Arthritis & Rheumatology Associates, P.C., Denton
El Paso Medical Research Institute (MedResearch, Inc), El Paso
e mais 1

RecrutandoEstudo observacional

Idades 16 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07175285

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

University of Texas MD Anderson Cancer Center, Houston

RecrutandoFase 1/2

Idades de 18 a 65 · Todos os sexos · Atualizado em 26 de ago. de 2026 · NCT06121297

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

Texas Transplant Institute, San Antonio

RecrutandoFase 2

Idades de 12 a 65 · Todos os sexos · Atualizado em 24 de ago. de 2026 · NCT07053800

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)

Integrative Rheumatology of South Texas - Harlingen /ID# 276458, Harlingen

RecrutandoFase 1

Idades de 18 a 75 · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT06977724

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

Prolato Clinical Research Center, Houston

RecrutandoFase 2

Idades de 18 a 100 · Todos os sexos · Atualizado em 30 de jul. de 2026 · NCT05268289

A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

Rheumatology Care Center, PLLC, Bellaire
Texas Arthritis Center, El Paso
Novel Research, LLC., Houston
e mais 3

RecrutandoFase 3

Idades de 18 a 75 · Todos os sexos · Atualizado em 30 de jul. de 2026 · NCT07201129

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

Investigative Site, Allen
Investigative Site, Arlington
Investigative Site, Colleyville

RecrutandoFase 2

Idades de 18 a 80 · Todos os sexos · Atualizado em 27 de jul. de 2026 · NCT07260877

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Accurate Clinical Research, League City
Epic Medical Research, Red Oak

RecrutandoFase 3

Idades de 12 a 100 · Todos os sexos · Atualizado em 8 de jul. de 2026 · NCT06133972

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

Stryde Research, Plano
Tranquil Clinical Research, Webster

RecrutandoFase 1

Idades de 18 a 70 · Todos os sexos · Atualizado em 5 de jun. de 2026 · NCT06613360

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

US04-0, Irving
US02-0, San Antonio

RecrutandoFase 1/2Voluntários saudáveis bem-vindos

Idades de 18 a 70 · Todos os sexos · Atualizado em 2 de jun. de 2026 · NCT06625671

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M D Anderson Cancer Center, Houston

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 20 de mai. de 2026 · NCT04751396

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

MD Anderson Cancer Center, Houston
The University of Texas Health Science Center at Houston, Houston

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 15 de abr. de 2026 · NCT06434363

Lupus Landmark Study: A Prospective Registry and Biorepository

UT Southwestern Medical Center, Dallas

RecrutandoEstudo observacional

Idades de 18 a 110 · Todos os sexos · Atualizado em 15 de abr. de 2026 · NCT05934149

A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)

Climb Bio Investigative Site #100104, Allen
Climb Bio Investigative Site #100101, San Antonio

RecrutandoFase 1

Idades de 18 a 65 · Todos os sexos · Atualizado em 27 de mar. de 2026 · NCT07011043

Fonte: ClinicalTrials.gov, dados obtidos em 1 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.